VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in acute care therapies, announced today the commercial launch of a new indication for the company’s oXiris set, which ...
BEIJING (Reuters) - China's Ministry of Commerce has approved Baxter International Inc's $4 billion bid for Sweden's Gambro AB provided Baxter sells its global continuous renal replacement therapy ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果